Back to Trades
Total Value
$100.0K
Filing Date
Nov 20, 2026
1 transaction
Grants
$100.0K
1 transaction
Trade Summary
On Nov 18, 2026, Mendelsohn Aaron, Director, received $100.0K of Vivani Medical, Inc. (VANI) across 1 transaction. The filing covers Common Stock and reflects balanced net activity of $0. Reported prices ranged from $1.01. Insider transactions are sourced from SEC Form 4 disclosures and should be reviewed alongside company fundamentals and the insider's broader trading history.
Company Information
- Company Name
- Vivani Medical, Inc.
- Ticker Symbol
- VANI
- CIK
- 0001266806
Insider Information
- Name
- Mendelsohn Aaron
- Role
- Director
- Location
- ALAMEDA, CA
Filing Details
- Filing Date
- Nov 20, 2026
- Transaction Date
- Nov 18, 2026
- Accession Number
- 0001753926-26-002220
- Form Type
- 4
Non-Derivative Transactions
| Date | Security | Shares | Price | Type | Value |
|---|---|---|---|---|---|
| Nov 18, 2026 | Common Stock | 99,010 | $1.01 | Grant/Award | $100.0K |
Want live alerts when Mendelsohn Aaron trades again?
Download Insider Trades to track VANI, follow insiders, and get mobile alerts when new SEC Form 4 filings are published.
Footnotes
- (F1)The reporting person purchased 99,010 shares of the Issuer's common stock in a private sale transaction as disclosed in the Share Purchase Agreement dated as of November 15, 2026 at a price of $1.01 per share, which was the last reported sale price of the Issuers common stock on the Nasdaq on November 13, 2026 (the trading day immediately prior to November 15, 2026). The gross proceeds from this private sale transaction were $100,000.10. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased in the transaction set forth in this footnote.
- (F2)On November 19, 2026, the reporting person filed a Form 4 which inadvertently included an incorrect transaction code due to an administrative error. This amendment is being filed to reflect the correct transaction code "A" instead of transaction code "D."
- (F3)The reporting person owns 1,165,497 shares directly and/or indirectly as follows: (i) 168,170 shares of common stock owned by the reporting person, (ii) 150,930 shares in five trusts, each of which has been established for a separate grandchild of the Reporting Person, with each trust owning an aggregate of 30,186 shares of common stock, all trusts with the same terms, over which the Reporting Person has voting and dispositive authority, (iii) 846,397 shares of common stock owned by MFE, LLC over which the Reporting Person has voting and dispositive authority. The Reporting Person disclaims pecuniary interest in 20% of MFE, LLC and therefore disclaims 169,279 shares of the 846,397 shares of common stock owned by MFE, LLC, which 169,279 shares are beneficially owned by other members of the limited liability company.